We are live on ! Find out more
HEC

Hudson Executive Capital Portfolio holdings

AUM $151M
1-Year Est. Return 60.14%
This Fund
S&P 500
This Quarter Est. Return
-5.03%
1 Year Est. Return
+60.14%
3 Year Est. Return
+143.92%
5 Year Est. Return
+104.85%
10 Year Est. Return
+677.02%
AUM
$1.33B
AUM Growth
-$89.1M
Cap. Flow
+$13.3M
Cap. Flow %
1%
Top 10 Hldgs %
100%
Holding
12
New
Increased
4
Reduced
Closed
2

Top Buys

Rank Stock Value
1
AKYA
Akoya BioSciences
AKYA
+$7.23M
2
VRAY
ViewRay, Inc.
VRAY
+$4.57M
3
TALK icon
Talkspace
TALK
+$2.86M
4
CTLP
Cantaloupe
CTLP
+$1.06M

Top Sells

Rank Stock Value
1
FLYX icon
flyExclusive
FLYX
+$2.36M
2
FLYX.WS icon
flyExclusive Inc Warrants
FLYX.WS
+$48K

Sector Composition

Rank Sector Weight
1 Financials 66.25%
2 Healthcare 18.08%
3 Technology 8.61%
4 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DB icon
1
Deutsche Bank
DB
$66.7B
$845M 63.38%
67,389,676
TVTY
2
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$127M 9.51%
4,795,310
CTLP
3
DELISTED
Cantaloupe
CTLP
$107M 8.06%
12,102,400
+106,635
+0.9% +$1.06M
VRAY
4
DELISTED
ViewRay, Inc.
VRAY
$85.5M 6.42%
15,524,623
+749,939
+5% +$4.57M
NTRA icon
5
Natera
NTRA
$37.9B
$55M 4.13%
588,886
EHTH icon
6
eHealth
EHTH
$43.8M
$38.3M 2.87%
1,501,002
AKYA
7
DELISTED
Akoya BioSciences
AKYA
$36.8M 2.76%
2,402,253
+552,410
+30% +$7.23M
TALK icon
8
Talkspace
TALK
$873M
$22.3M 1.68%
11,340,600
+1,000,000
+10% +$2.86M
BLND icon
9
Blend Labs
BLND
$424M
$7.34M 0.55%
1,000,000
FLYX icon
10
flyExclusive
FLYX
$61.1M
-242,849
Closed -$2.36M
FLYX.WS icon
11
flyExclusive Inc Warrants
FLYX.WS
-80,949
Closed -$48K

Similar funds

Hudson Executive Capital's Q4 2021 Portfolio in Review

As of Q4 2021, Hudson Executive Capital held 12 positions worth $1.33B, down 6.3% from $1.42B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Hudson Executive Capital's Q4 2021 filing shows 4 increased and 2 closed positions. The largest sale was flyExclusive, an estimated $2.36M.

By sector, the portfolio is most concentrated in Financials at 66% of assets, up from 65% a quarter earlier, followed by Healthcare and Technology.

  • Hudson Executive Capital added most to Akoya BioSciences in Q4 2021, an estimated $7.23M increase.
  • Hudson Executive Capital fully exited flyExclusive in Q4 2021, selling an estimated $2.36M.
  • Hudson Executive Capital's ten largest holdings make up 100% of its $1.33B portfolio in Q4 2021.
  • Hudson Executive Capital opened 0 new positions and closed 2 in Q4 2021.
  • Hudson Executive Capital's portfolio value fell 6.3% quarter-over-quarter to $1.33B.

Based on Hudson Executive Capital's 13F filing for Q4 2021, filed 14 Feb 2022.